Chemoinformaics analysis of 2-HYDROXY-6-PENTADECYLBENZOIC ACID
| Molecular Weight | 348.527 | nRot | 15 |
| Heavy Atom Molecular Weight | 312.239 | nRig | 6 |
| Exact Molecular Weight | 348.266 | nRing | 1 |
| Solubility: LogS | -5.31 | nHRing | 0 |
| Solubility: LogP | 5.399 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 63.1505 |
| nHD | 2 | BPOL | 36.9835 |
| QED | 0.756 |
| Synth | 2.16 |
| Natural Product Likeliness | 0.041 |
| NR-PPAR-gamma | 0.943 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.7 |
| Pgp-sub | 0.005 |
| HIA | 0.922 |
| CACO-2 | -5.273 |
| MDCK | 0.0000104 |
| BBB | 0.369 |
| PPB | 0.999838 |
| VDSS | 5.204 |
| FU | 0.0305478 |
| CYP1A2-inh | 0.791 |
| CYP1A2-sub | 0.939 |
| CYP2c19-inh | 0.606 |
| CYP2c19-sub | 0.82 |
| CYP2c9-inh | 0.475 |
| CYP2c9-sub | 0.764 |
| CYP2d6-inh | 0.849 |
| CYP2d6-sub | 0.801 |
| CYP3a4-inh | 0.496 |
| CYP3a4-sub | 0.696 |
| CL | 5.342 |
| T12 | 0.274 |
| hERG | 0.009 |
| Ames | 0.005 |
| ROA | 0.1 |
| SkinSen | 0.795 |
| Carcinogencity | 0.024 |
| EI | 0.953 |
| Respiratory | 0.601 |
| NR-Aromatase | 0.031 |
| Antiviral | Yes |
| Prediction | 0.626958 |